首页> 外国专利> Methods for Screening Therapeutics for X-linked Adrenoleukodystrophy and Autologous Differentiated Oligodendrocytes Therefor

Methods for Screening Therapeutics for X-linked Adrenoleukodystrophy and Autologous Differentiated Oligodendrocytes Therefor

机译:X联肾上腺皮质营养不良症及其自体分化少突胶质细胞治疗药物的筛选方法

摘要

The invention Station in inducing differentiation and de-differentiation induced pluripotent stem cell method for producing a pluripotent stem cell relates to the X- associated Adrenoleukodystrophy disease screening method using a cell . The present invention can be produced X- associated Adrenoleukodystrophy (X-linked adrenoleukodystrophy, X-ALD) de-differentiation induced pluripotent stem cells from human fibroblasts derived from a patient . May also be used to reverse the diluent projection differentiated glial differentiation-inducing pluripotent stem cells to determine the efficacy of a drug through the screening method of the X- associated Adrenoleukodystrophy therapeutic candidates . In particular, de-differentiation induced pluripotent stem cells can self (autologous) by making a rare glial turning the advantage of patient-specific treatment is available through the production process . ;
机译:诱导分化和去分化诱导的多能干细胞的方法产生多能干细胞的方法本发明涉及使用细胞的X相关性肾上腺皮质营养不良疾病的筛选方法。可以从得自患者的人成纤维细胞中产生本发明的X-相关的肾上腺皮质营养不良症(X-linked adrenoleukodystrophy,X-ALD)去分化诱导的多能干细胞。也可用于逆转稀释剂投射分化诱导胶质细胞分化的多能干细胞,以通过X相关肾上腺皮质营养不良治疗候选药物的筛选方法确定药物的功效。特别地,去分化诱导的多能干细胞可以通过进行罕见的神经胶质转化而自我(自体),在生产过程中可以利用患者特异性治疗的优势。 ;

著录项

  • 公开/公告号KR101323652B1

    专利类型

  • 公开/公告日2013-11-05

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20110048521

  • 发明设计人 장지호;김동욱;강훈철;

    申请日2011-05-23

  • 分类号C12N5/0735;C12N5/10;C12N15/867;C12N15/12;

  • 国家 KR

  • 入库时间 2022-08-21 16:24:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号